Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Amgen and Merck are currently competing against each other in the market for investor capital.Sub-event
The three companies are noted as major, large-cap drug manufacturers operating in the US market.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Merck
public company in Indonesia
-
Amgen
American multinational biopharmaceutical company
Related events
- Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.
- Merck's stock price increased following positive drug performance involving Summit Therapeutics.
- Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.
- Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.
- Merck has set the list price for a drug that received approval from the FDA.